BARCLAYS PLC - HAEMONETICS CORP MASS ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of HAEMONETICS CORP MASS
ValueSharesWeighting
Q3 2023$134
-26.0%
154,000
-27.0%
0.00%
Q2 2023$181
-77.3%
211,000
-77.5%
0.00%
Q1 2023$797
-44.5%
936,000
-45.8%
0.00%
-100.0%
Q4 2022$1,437
-98.2%
1,726,000
+1626.0%
0.00%
Q3 2022$80,000100,0000.00%
Other shareholders
HAEMONETICS CORP MASS shareholders Q4 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 17,558$15,0281.36%
OSTERWEIS CAPITAL MANAGEMENT INC 18,000,000$15,406,1541.02%
ADVENT CAPITAL MANAGEMENT /DE/ 53,348,000$45,660,4170.88%
DeepCurrents Investment Group LLC 24,371,000$20,841,7960.82%
MACKAY SHIELDS LLC 29,499,000$25,204,7360.70%
SSI INVESTMENT MANAGEMENT LLC 11,208,000$9,536,8590.67%
Aequim Alternative Investments LP 20,500,000$17,545,8980.66%
Quaero Capital S.A. 900,000$769,6350.59%
READYSTATE ASSET MANAGEMENT LP 8,000,000$6,847,1800.52%
Empyrean Capital Partners, LP 12,000,000$10,215,0000.46%
View complete list of HAEMONETICS CORP MASS shareholders